{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T23:28:27Z","timestamp":1782689307272,"version":"3.54.5"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEOR"],"DOI":"10.2147\/ceor.s156558","type":"journal-article","created":{"date-parts":[[2019,12,15]],"date-time":"2019-12-15T16:39:36Z","timestamp":1576427976000},"page":"789-798","source":"Crossref","is-referenced-by-count":10,"title":["<p>North American cost analysis of brand name versus generic drugs for the treatment of glaucoma<\/p>"],"prefix":"10.2147","volume":"Volume 11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7875-7386","authenticated-orcid":true,"given":"Monali S","family":"Malvankar-Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy ML","family":"Hutnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,12]]},"container-title":["ClinicoEconomics and Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=54741","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=54741","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,15]],"date-time":"2019-12-15T16:39:38Z","timestamp":1576427978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/north-american-cost-analysis-of-brand-name-versus-generic-drugs-for-th-peer-reviewed-article-CEOR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ceor.s156558","relation":{},"ISSN":["1178-6981"],"issn-type":[{"value":"1178-6981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}